Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Novel Protein Nanoparticles ‘Shape’ the Future of Disease

Abstract:
Researchers at the University of North Carolina-Chapel Hill (UNC) have granted an exclusive license to Liquidia Technologies for a protein particle fabrication method that could greatly expand the reach of protein therapeutics. Proteins are large organic molecules that perform highly specific and complex functions in the body, making them an ideal instrument to diagnose and cure disease. However, protein solubility, distribution, stability, and aggregation have hampered the development of this therapeutic class.

Novel Protein Nanoparticles ‘Shape’ the Future of Disease

Research Triangle Park, NC | Posted on May 14th, 2008

Using a nano-fabrication process known as PRINT® (Particle Replication in Non-Wetting Templates), the researchers formed protein particles of pure insulin and albumin, as well as albumin particles containing therapeutics such as siRNA and paclitaxel. These particles are designed with a predetermined size and shape profile that may optimize protein stability, solubility, and concentration, while minimizing inter-particle forces that cause aggregation.

"We expect this discovery to dramatically expand the capability and efficacy of existing protein therapeutics," said Joseph DeSimone, Liquidia founder and professor of chemistry and chemical engineering at UNC. "Design of protein particles in such a way that affords control over size and shape, and preserves protein biofunctionality, has never before been accomplished."

Unlike previous techniques, which have produced "polydisperse" particle mixtures with sizes ranging from hundreds of nanometers to tens of microns, the PRINT process forms particles of uniform size and shape. Liquidia Technologies has obtained a worldwide license to all rights for the PRINT platform and is working with partners to design protein particle therapeutics for effective delivery to the lung and other targets.

"This technology has the unique opportunity to overcome the challenges associated with protein therapeutics and contribute to the development of highly specific therapeutics for a wide range of diseases," says Liquidia CEO, Neal Fowler. "Having recently led a company that specializes in developing and commercializing biologics, I have a great appreciation and excitement for the new biotherapeutic opportunities that the PRINT platform may enable."

DeSimone and Jennifer Kelly, a graduate student in DeSimone's lab, led the research effort at UNC. Their work was published in the April 23 issue of the Journal of the American Chemical Society.

####

About Liquidia Technologies
Liquidia Technologies Inc. is a privately-held nanotechnology company that designs, develops, and manufactures precisely engineered particles and films for a wide variety of life and materials science applications. Within life sciences, Liquidia is focused on the development of Engineered Drug Therapies™ for nucleic acid delivery, and highly targeted therapeutics for the treatment of cancer and other diseases. The company was founded in 2004 on the discoveries of Professor Joseph DeSimone and colleagues at the University of North Carolina, Chapel Hill and is located in Research Triangle Park, North Carolina.

For more information, please click here

Contacts:


Liquidia Technologies
Elle Pishny
919-328-4361

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New exotic phenomena seen in photonic crystals: Researchers observe, for the first time, topological effects unique to an “open” system January 12th, 2018

'Decorated' stem cells could offer targeted heart repair January 11th, 2018

Nanotube fibers in a jiffy: Rice University lab makes short nanotube samples by hand to dramatically cut production time January 11th, 2018

IBM Breaks Records to Top U.S. Patent List for 25th Consecutive Year: IBM Inventors Receive Record 9,043 Patents in 2017 in Areas such as Artificial Intelligence, Cloud, Blockchain, Cybersecurity and Quantum Computing January 11th, 2018

Nanomedicine

'Decorated' stem cells could offer targeted heart repair January 11th, 2018

Rice University lab modifies nanoscale virus to deliver peptide drugs to cells, tissues January 8th, 2018

SNUH team develops new nanomaterial for thermal cancer therapy January 5th, 2018

Novel nanomedicine inhibits progression of pancreatic cancer in mice: Survival rates in pancreatic cancer linked to inverse correlation between specific oncogene and tumor suppressant, Tel Aviv University researchers say January 3rd, 2018

Announcements

New exotic phenomena seen in photonic crystals: Researchers observe, for the first time, topological effects unique to an “open” system January 12th, 2018

'Decorated' stem cells could offer targeted heart repair January 11th, 2018

Nanotube fibers in a jiffy: Rice University lab makes short nanotube samples by hand to dramatically cut production time January 11th, 2018

IBM Breaks Records to Top U.S. Patent List for 25th Consecutive Year: IBM Inventors Receive Record 9,043 Patents in 2017 in Areas such as Artificial Intelligence, Cloud, Blockchain, Cybersecurity and Quantum Computing January 11th, 2018

Patents/IP/Tech Transfer/Licensing

IBM Breaks Records to Top U.S. Patent List for 25th Consecutive Year: IBM Inventors Receive Record 9,043 Patents in 2017 in Areas such as Artificial Intelligence, Cloud, Blockchain, Cybersecurity and Quantum Computing January 11th, 2018

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

Chinese market opens up for Carbodeon nanodiamonds: Carbodeon granted Chinese Patent for Nanodiamond-containing Thermoplastic Thermal Compounds December 4th, 2017

Picosun’s ALD nanolaminates improve lifetime and reliability of electronic circuit boards October 24th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project